Nu-Med Plus (NUMD) Enterprise Value Growth (3y) (2014 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.18% |
| Sep 30, 2025 | -45.84% |
| Mar 31, 2025 | 2.20% |
| Dec 31, 2024 | 41.20% |
| Sep 30, 2024 | 49.75% |
| Jun 30, 2024 | 61.86% |
| Mar 31, 2024 | 64.26% |
| Dec 31, 2023 | 66.95% |
| Sep 30, 2023 | 29.39% |
| Jun 30, 2023 | -69.92% |
| Mar 31, 2023 | -42.49% |
| Dec 31, 2022 | -117.86% |
| Sep 30, 2022 | 75.33% |
| Mar 31, 2022 | 52.23% |
| Dec 31, 2021 | 58.85% |
| Sep 30, 2021 | 42.59% |
| Jun 30, 2021 | 36.79% |
| Mar 31, 2021 | 20.33% |
| Dec 31, 2020 | 18.72% |
| Sep 30, 2020 | 57.47% |